Novel pathophysiological insights into CAR-T cell associated neurotoxicity
Chimeric antigen receptor (CAR) T cell therapy represents a scientific breakthrough in the treatment of advanced hematological malignancies. It relies on cell engineering to direct the powerful cytotoxic T-cell activity toward tumor cells. Nevertheless, these highly powerful cell therapies can trigg...
Main Authors: | Vassilis Genoud, Denis Migliorini |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1108297/full |
Similar Items
-
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome
by: Tim Lakomy, et al.
Published: (2023-02-01) -
CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap
by: Lidia Gatto, et al.
Published: (2023-06-01) -
Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell Therapies
by: Christopher Schorr, et al.
Published: (2023-05-01) -
Secretory co-factors in next-generation cellular therapies for cancer
by: Atsushi Okuma, et al.
Published: (2022-08-01) -
A systematic framework for predictive biomarkers in immune effector cell-associated neurotoxicity syndrome
by: Omar H. Butt, et al.
Published: (2023-02-01)